Dermatology Stocks
Advanced therapeutic and diagnostic entities in this sector target chronic inflammatory conditions, oncological malignancies of the skin, and regenerative wound healing through specialized biologic and small-molecule interventions.
As of Oct 23, 2026, Dermatology has 52 US-listed companies worth $220B combined. The median member moved +2.3% over the past week; MANE led among the 25 largest at +27.5% and VTRS trailed at -3.5%.
Companies in Dermatology
- GALDY – GALDERMA GROUP AG, $54B
- ZTS – Zoetis Inc, $33.9B
- ROIV – Roivant Sciences Ltd, $27.1B
- INCY – Incyte Corporation, $23.7B
- VTRS – Viatris Inc, $21.2B
- KRYS – Krystal Biotech Inc, $9.6B
- PTGX – Protagonist Therapeutics Inc, $9B
- HIMS – Hims Hers Health Inc, $6.8B
- MANE – Veradermics, Incorporated, $5.8B
- ORKA – Oruka Therapeutics, Inc., $5.2B
- ARQT – Arcutis Biotherapeutics Inc, $4B
- PLSE – Pulse Biosciences Inc, $3.7B
- BHC – Bausch Health Companies Inc, $2.4B
- CLDX – Celldex Therapeutics Inc, $2.3B
- PVLA – Palvella Therapeutics, Inc, $1.7B
- NKTR – Nektar Therapeutics, $1.2B
- CSTL – Castle Biosciences Inc, $1.1B
- ALMS – Alumis Inc, $885M
- MLTX – MoonLake Immunotherapeutics, $813M
- INMD – InMode Ltd, $811M
- SBC – SBC Medical Group Holdings Incorporated, $538M
- ACRS – Aclaris Therapeutics Inc, $483M
- EOLS – Evolus Inc, $472M
- TRXB – TRex Bio, Inc. Common stock, $384M
- TTRX – Turn Therapeutics Inc. Common Stock, $337M
- CUVL – Clinuvel Pharmaceuticals Limited American Depositary Shares, $262M
- ABEO – Abeona Therapeutics Inc, $252M
- QTTB – Q32 Bio Inc, $232M
- SLGL – Sol Gel Technologies Ltd, $227M
- IFRX – InflaRx N.V., $223M
- EVMN – Evommune, Inc., $188M
- DERM – Journey Medical Corp, $160M
- PTHS – Pelthos Therapeutics Inc., $85M
- SKIN – Beauty Health Co, $76.8M
- VRCA – Verrica Pharmaceuticals Inc, $70.6M
- FBIO – Fortress Biotech Inc, $67.7M
- CNTB – Connect Biopharma Holdings Ltd, $56.7M
- ELOX – Eloxx Pharmaceuticals, Inc., $53M
- IMA – ImageneBio, Inc., $52.4M
- SRTS – Sensus Healthcare Inc, $47.1M
- EDSA – Edesa Biotech Inc, $36.1M
- QNRX – Quoin Pharmaceuticals Ltd DRC, $21.9M
- HIND – Vyome Holdings, Inc., $13.8M
- CABR – Caring Brands, Inc. Common Stock, $13.4M
- BFRI – Biofrontera Inc, $12M
- AZTR – Azitra Inc, $7.9M
- APUS – Apimeds Pharmaceuticals US, Inc., $6.1M
- SNOA – Sonoma Pharmaceuticals Inc, $5.8M
- DRMA – Dermata Therapeutics Inc, $5.6M
- MDCX – Medicus Pharma Ltd. Common Stock, $3.8M
- EVLO – Evelo Biosciences Inc, $3,796
- SSKN – STRATA Skin Sciences Inc, $1,177